Literature DB >> 19622398

Autoimmune pancreatitis: an underdiagnosed autoimmune disease with clinical, imaging and serological features.

María Sánchez-Castañón1, Gonzalo de las Heras-Castaño, Marcos López-Hoyos.   

Abstract

Since Sarles et al. [Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am J Dig Dis 1961; 6: 688-698.] reported a case of pancreatitis associated with hypergammaglobulinemia, many cases have been described, which led to the current concept of "autoimmune pancreatitis (AIP)". Lymphoplasmacytic infiltration and fibrosis on histology together with elevated IgG levels or the presence of autoantibodies on laboratory examinations supported the concept of AIP. In recent years, based on histological and immunohistochemical examination of various organs of patients with AIP, a novel clinicopathological entity, IgG4-related slerosing disease, has been proposed. AIP is a systemic disease that is characterized by dense infiltration of IgG4-positive plasma cells and T lymphocytes in various organs. Clinical manifestations are related with pancreas dysfunction but other organs may be affected such as bile duct, gallbladder, salivary gland, retroperitoneum, kidney, lung and prostate. Increased serum IgG4 levels, the presence of several autoantibodies such as anti-carbonic anhydrase II antibodies (ACA-II), immunostaining IgG4 positive in pancreas tissue and a very good response to steroid therapy are useful for the diagnosis of AIP that can mimic pancreatic cancer. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622398     DOI: 10.1016/j.autrev.2009.07.003

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  3 in total

1.  Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry.

Authors:  Mojca Bizjak; Or Bruck; Sonja Praprotnik; Shani Dahan; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

2.  The Presence of Serum TgAb Suggests Lower Risks for Glucose and Lipid Metabolic Disorders in Euthyroid General Population From a National Survey.

Authors:  Jinjia Zhang; Yiyang Gao; Yongze Li; Di Teng; Yuanming Xue; Li Yan; Jing Yang; Lihui Yang; Yongli Yao; Jianming Ba; Bing Chen; Jianling Du; Lanjie He; Xiaoyang Lai; Xiaochun Teng; Xiaoguang Shi; Yanbo Li; Haiyi Chi; Eryuan Liao; Chao Liu; Libin Liu; Guijun Qin; Yingfen Qin; Huibiao Quan; Bingyin Shi; Hui Sun; Xulei Tang; Nanwei Tong; Guixia Wang; Jin-An Zhang; Youmin Wang; Zhen Ye; Qiao Zhang; Lihui Zhang; Jun Zhu; Mei Zhu; Weiping Teng; Zhongyan Shan; Jing Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-18       Impact factor: 5.555

3.  Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure.

Authors:  Chengeng Liu; Yue Wei; Jianmin Wang; Langan Pi; Jianjun Huang; Peichang Wang
Journal:  Clin Dev Immunol       Date:  2012-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.